184 related articles for article (PubMed ID: 33734109)
1. MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Donís SP; González AP; Alves MGO; do Carmo Carvalho BF; Ferreira CCP; Almeida JD; Iruegas EP; Petronacci CMC; Peñaranda JMS; Sayáns MP
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):613-618. PubMed ID: 33734109
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA repair genes in oral squamous cell carcinoma using reverse transcription-quantitative polymerase chain reaction.
Oliveira Alves MG; da Silva Miguel N; Ferreira CCP; Alvarenga ER; Tonon BM; de Barros PP; Carta CFL; Paschoal MBN; de Sales Chagas JF; Bandeira CM; Nunes FD; Almeida JD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):298-305. PubMed ID: 32682592
[TBL] [Abstract][Full Text] [Related]
3. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
5. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
[TBL] [Abstract][Full Text] [Related]
6. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
7. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of p-Smad3 in oral carcinogenesis.
Poomsawat S; Punyasingh J; Vejchapipat P
Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
[TBL] [Abstract][Full Text] [Related]
9. Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.
Chaudhari NT; Tupkari JV; Joy T; Ahire MS
J Oral Maxillofac Pathol; 2016; 20(3):453-461. PubMed ID: 27721611
[TBL] [Abstract][Full Text] [Related]
10. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
[No Abstract] [Full Text] [Related]
12. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
14. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
[TBL] [Abstract][Full Text] [Related]
17. LAMC2 is a predictive marker for the malignant progression of leukoplakia.
Nguyen CT; Okamura T; Morita KI; Yamaguchi S; Harada H; Miki Y; Izumo T; Kayamori K; Yamaguchi A; Sakamoto K
J Oral Pathol Med; 2017 Mar; 46(3):223-231. PubMed ID: 27529842
[TBL] [Abstract][Full Text] [Related]
18. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
19. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
[TBL] [Abstract][Full Text] [Related]
20. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
